• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2

tetano

Editor, Senior Moderator
J Med Virol


. 2021 Feb 27.
doi: 10.1002/jmv.26911. Online ahead of print.
Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2


Asim Zahoor Abbasi[SUP] 1 [/SUP], Dania Akram Kiyani[SUP] 1 [/SUP], Syeda Maira Hamid[SUP] 1 [/SUP], Muhammad Saalim[SUP] 2 3 [/SUP], Ammad Fahim[SUP] 4 [/SUP], Nasir Jalal[SUP] 5 6 [/SUP]



Affiliations

Abstract

Epidemiological data shows discrepancy in COVID-19 susceptibility and outcomes with some regions being more heavily affected than others. However, the factors that determine host susceptibility and pathogenicity remain elusive. Increasing number of publications highlight the role of Transmembrane Serine Protease 2 (TMPRSS2) in the susceptibility of host cell to SARS-CoV-2. Cleavage of viral spike protein via the host cell's TMPRSS2 enzyme activity mediates viral entry into the host cell. The enzyme synthesis is regulated by TMPRSS2 gene, which has also been implicated in the entry mechanisms of previously reported Coronavirus infections. In this review we have investigated the pathogenicity of SARS-CoV-2 and disease susceptibility dependence on TMPRSS2 gene as expressed in various population groups. We further discuss how the differential expression of this gene in various ethnic groups can affect the SARS-CoV-2 infection and Coronavirus disease (COVID)-19 outcomes. Moreover, promising new TMPRSS2 protease blockers and inhibitors are discussed for COVID-19 treatment. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; Coronavirus; Differential gene expression; SARS-CoV-2; TMPRSS2; TMPRSS2 Blockers; TMPRSS2 Inhibitors; Viral entry.
 
Back
Top Bottom